Federica Fogacci Presents The New ILEP Consensus Paper
Federica Fogacci, Young Fellow at European Atherosclerosis Society, shared on LinkedIn:
”Rethinking lipid management for stroke prevention – new ILEP Consensus Paper
Ischemic stroke accounts for ~66% of all strokes and is now the third leading cause of death worldwide – yet a large proportion of patients still have undiagnosed or undertreated lipid disorders, both before and after a cerebrovascular event.
Together with an amazing international team from the International Lipid Expert Panel (ILEP), in collaboration with the ESC Council on Stroke, we have just published a new consensus paper on lipid management for primary and secondary stroke prevention in Progress in Cardiovascular Diseases
What’s inside the paper?
- Why dyslipidaemia (including LDL-C and Lp(a)) is a causal driver of ischaemic stroke
- Clear, pragmatic LDL-C and apoB targets for patients at risk of stroke and for those with prior stroke/TIA
- A strong message in favour of early, intensive and often combination lipid-lowering therapy (statins + ezetimibe ± PCSK9 inhibitors, bempedoic acid, inclisiran) to close the huge treatment gap in real-world practice
- How to think about Lp(a), triglyceride-rich lipoproteins, and non-HDL-C in stroke prevention
- The ILEP-SMILE framework: simple lifestyle “tips for the healthy cerebrum” to integrate pharmacological and non-pharmacological prevention
Our message is simple – and fully implementable in everyday practice:
“Lower is better, earlier is better, and longer is better” for LDL-C and overall lipid management in patients at risk of stroke and after stroke.
Even partial, consistent implementation of these principles could translate into fewer strokes and better long-term outcomes for our patients.”
Read the full article here.
Article: Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP)
Authors: Maciej Banach, Peter P. Toth, Hyo-Jeong Ahn, Agata Bielecka-Dabrowa, Arrigo F.G. Cicero, Adrian Covic, Mayank Dalakoti, Carlos Escobar, Federica Fogacci, Dan Gaita, Laura Gaita, Jacek Jóźwiak, Gustavs Latkovskis, Joanna Lewek, George Ntaios, Boguslaw Okopień, Ivan Pećin, Daniel Pella, Peter E. Penson, Marco Proietti, Gregory Y.H. Lip
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 22, 2026, 16:16Christopher Pittman: Superficial Venous Disease Needs Arterial-Level Follow-Up
-
Apr 22, 2026, 15:47Mohammed Alo: Being Fit Does Not Protect You from High LDL
-
Apr 22, 2026, 15:28ASH Committee Brings the Voice of Hematology to Capitol Hill
-
Apr 22, 2026, 15:22Stephen Pendergast: Are Universal Shelf Stable Blood Substitutes Finally Within Reach?
-
Apr 22, 2026, 14:51Mavis Agnes Kisakye: Reconnecting to Drive the Global Bleeding Disorders Agenda Forward
-
Apr 22, 2026, 14:48Augustina Isioma Ikusemoro: Not Every Antigen Speaks Loudly, But the Right Test Will Hear It
-
Apr 22, 2026, 14:47Karuna Kumar: Busting the Myth about Increasing Infection Risk by IV Iron
-
Apr 22, 2026, 14:46David Brown: Charting a New Path Forward for One Patient Facing Extraordinary Cardiac Challenges
-
Apr 22, 2026, 14:45Ney Carter Borges: Syphilis and Cardiovascular Risk – A Silent and Progressive Vascular Burden